Also known as a Lymphoplasmacytic Lymphoma (LPL), this very rare indolent Non-Hodgen's Lymphoma
has a world wide incidence of about five in a million people.
We aim to help you, live with, rather than worry about dying, of Waldenströms. Thanks to ongoing research and treatment options many WMers live much longer and with a better quality of life today.
Screenshot from our May Zoom meeting.
Next Zoom meeting to be announced.
Ed Forum planning for 2022 is in the works! Our 27th annual Ed Forum will be entirely virtual this year. Experience expert-led programming for the Waldenstrom macroglobulinemia community from newly diagnosed patients, to 25+ year WM veterans, and everyone in-between. Check back here for the agenda and announcements.